Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue
Orthopedic product sales	$ 12,950	$ 12,509
Other revenue	9	33
Total Revenue	12,959	12,542
Cost of sales	5,399	4,451
Gross Profit	7,560	8,091
Operating Expenses
General and administrative	3,969	3,027
Sales and marketing	5,209	4,855
Research and development	213	214
Total Operating Expenses	9,391	8,096
Loss from Operations	(1,831)	(5)
Other Expense
Interest expense	(359)	(1)
Total Other Expense	(359)	(1)
Net Loss from Operations Before Provision for Income Taxes	(2,190)	(6)
Provision for Income Taxes Current and Deferred	(23)	(23)
Net Loss	$ (2,213)	$ (29)
Net Loss Per Share:
Basic	$ (0.03)	$ (0.00)
Dilutive	$ (0.03)	$ (0.00)
Shares used in the computation:
Basic	87,191,341	81,248,875
Dilutive	87,191,341	81,248,875